189 related articles for article (PubMed ID: 23410953)
1. Identification and characterization of bi-thiazole-2,2'-diamines as kinase inhibitory scaffolds.
Ngoei KR; Ng DC; Gooley PR; Fairlie DP; Stoermer MJ; Bogoyevitch MA
Biochim Biophys Acta; 2013 Jun; 1834(6):1077-88. PubMed ID: 23410953
[TBL] [Abstract][Full Text] [Related]
2. Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases.
Comess KM; Sun C; Abad-Zapatero C; Goedken ER; Gum RJ; Borhani DW; Argiriadi M; Groebe DR; Jia Y; Clampit JE; Haasch DL; Smith HT; Wang S; Song D; Coen ML; Cloutier TE; Tang H; Cheng X; Quinn C; Liu B; Xin Z; Liu G; Fry EH; Stoll V; Ng TI; Banach D; Marcotte D; Burns DJ; Calderwood DJ; Hajduk PJ
ACS Chem Biol; 2011 Mar; 6(3):234-44. PubMed ID: 21090814
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of disubstituted thiophene and thiazole based inhibitors of JNK.
Hom RK; Bowers S; Sealy JM; Truong AP; Probst GD; Neitzel ML; Neitz RJ; Fang L; Brogley L; Wu J; Konradi AW; Sham HL; Tóth G; Pan H; Yao N; Artis DR; Quinn K; Sauer JM; Powell K; Ren Z; Bard F; Yednock TA; Griswold-Prenner I
Bioorg Med Chem Lett; 2010 Dec; 20(24):7303-7. PubMed ID: 21071223
[TBL] [Abstract][Full Text] [Related]
4. Differential roles of JNK, ERK1/2, and p38 mitogen-activated protein kinases on endothelial cell tissue repair functions in response to tumor necrosis factor-α.
Kanaji N; Nelson A; Wang X; Sato T; Nakanishi M; Gunji Y; Basma H; Michalski J; Farid M; Rennard SI; Liu X
J Vasc Res; 2013; 50(2):145-56. PubMed ID: 23258237
[TBL] [Abstract][Full Text] [Related]
5. Galloyl benzamide-based compounds modulating tumour necrosis factor α-stimulated c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signalling pathways.
Leo V; Stefanachi A; Nacci C; Leonetti F; de Candia M; Carotti A; Altomare CD; Montagnani M; Cellamare S
J Pharm Pharmacol; 2015 Oct; 67(10):1380-92. PubMed ID: 26078032
[TBL] [Abstract][Full Text] [Related]
6. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor.
Sutherland CL; Heath AW; Pelech SL; Young PR; Gold MR
J Immunol; 1996 Oct; 157(8):3381-90. PubMed ID: 8871635
[TBL] [Abstract][Full Text] [Related]
7. Arachidonic acid directly activates members of the mitogen-activated protein kinase superfamily in rabbit proximal tubule cells.
Alexander LD; Cui XL; Falck JR; Douglas JG
Kidney Int; 2001 Jun; 59(6):2039-53. PubMed ID: 11380805
[TBL] [Abstract][Full Text] [Related]
8. Targeted covalent inactivation of protein kinases by resorcylic acid lactone polyketides.
Schirmer A; Kennedy J; Murli S; Reid R; Santi DV
Proc Natl Acad Sci U S A; 2006 Mar; 103(11):4234-9. PubMed ID: 16537514
[TBL] [Abstract][Full Text] [Related]
9. Roles of mitogen-activated protein kinase pathways during Escherichia coli-induced apoptosis in U937 cells.
Wang JH; Zhou YJ; He P; Chen BY
Apoptosis; 2007 Feb; 12(2):375-85. PubMed ID: 17191113
[TBL] [Abstract][Full Text] [Related]
10. Selective targeting of MAPK family kinases JNK over p38 by rationally designed peptides as potential therapeutics for neurological disorders and epilepsy.
Zhuo ZH; Sun YZ; Jin PN; Li FY; Zhang YL; Wang HL
Mol Biosyst; 2016 Jul; 12(8):2532-40. PubMed ID: 27263470
[TBL] [Abstract][Full Text] [Related]
11. Selectivity of docking sites in MAPK kinases.
Bardwell AJ; Frankson E; Bardwell L
J Biol Chem; 2009 May; 284(19):13165-73. PubMed ID: 19196711
[TBL] [Abstract][Full Text] [Related]
12. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
[TBL] [Abstract][Full Text] [Related]
13. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways.
Liu W; Liang Q; Balzar S; Wenzel S; Gorska M; Alam R
J Allergy Clin Immunol; 2008 Apr; 121(4):893-902.e2. PubMed ID: 18395552
[TBL] [Abstract][Full Text] [Related]
14. Evidence for JNK-dependent up-regulation of proteoglycan synthesis and for activation of JNK1 following cyclical mechanical stimulation in a human chondrocyte culture model.
Zhou Y; Millward-Sadler SJ; Lin H; Robinson H; Goldring M; Salter DM; Nuki G
Osteoarthritis Cartilage; 2007 Aug; 15(8):884-93. PubMed ID: 17408985
[TBL] [Abstract][Full Text] [Related]
15. A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase.
Fox T; Coll JT; Xie X; Ford PJ; Germann UA; Porter MD; Pazhanisamy S; Fleming MA; Galullo V; Su MS; Wilson KP
Protein Sci; 1998 Nov; 7(11):2249-55. PubMed ID: 9827991
[TBL] [Abstract][Full Text] [Related]
16. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
Chuang SM; Wang IC; Yang JL
Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
[TBL] [Abstract][Full Text] [Related]
17. Activation of mitogen-activated protein kinase cascades during priming of human neutrophils by TNF-alpha and GM-CSF.
McLeish KR; Knall C; Ward RA; Gerwins P; Coxon PY; Klein JB; Johnson GL
J Leukoc Biol; 1998 Oct; 64(4):537-45. PubMed ID: 9766635
[TBL] [Abstract][Full Text] [Related]
18. A novel retro-inverso peptide is a preferential JNK substrate-competitive inhibitor.
Ngoei KR; Catimel B; Milech N; Watt PM; Bogoyevitch MA
Int J Biochem Cell Biol; 2013 Aug; 45(8):1939-50. PubMed ID: 23792175
[TBL] [Abstract][Full Text] [Related]
19. Regulation of hairy-cell survival through constitutive activation of mitogen-activated protein kinase pathways.
Kamiguti AS; Harris RJ; Slupsky JR; Baker PK; Cawley JC; Zuzel M
Oncogene; 2003 Apr; 22(15):2272-84. PubMed ID: 12700663
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of a survival signal in the ischemic heart by resveratrol through p38 mitogen-activated protein kinase/mitogen- and stress-activated protein kinase 1/cAMP response element-binding protein signaling.
Das S; Tosaki A; Bagchi D; Maulik N; Das DK
J Pharmacol Exp Ther; 2006 Jun; 317(3):980-8. PubMed ID: 16525036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
